Kanamic Network Co Ltd

Kanamic Network Co Ltd maintains a strong liquidity position, with a current ratio of 2.76 and cash and equivalents amounting to 3,327,111,000 JPY, indicating a solid ability to meet short-term obligations. The company's debt-to-equity ratio is 0.14, suggesting a conservative capital structure with minimal reliance on debt financing. The return on equity of 0.2391 and return on assets of 0.1699 highlight the company's efficient use of equity and assets to generate profits. In terms of profitability, Kanamic Network Co Ltd's operating income of 1,599,942,000 JPY and net income of 1,111,529,000 JPY reflect a healthy margin, with the company's return on equity and return on assets outperforming the industry median for healthcare technology firms. The company's gross profit of 3,536,422,000 JPY further underscores its strong cost management and pricing power. Kanamic Network Co Ltd's revenue is primarily concentrated in the healthcare technology segment, with no disclosed geographic revenue breakdown. The company's business model is centered around biotechnology services and equipment, with no material diversification across product lines or geographic regions. Looking ahead, Kanamic Network Co Ltd is projected to see a revenue increase, with analysts estimating 6,350,000,000 JPY for the upcoming fiscal year, compared to the actual revenue of 5,500,786,000 JPY in the most recent period. The company's free cash flow of 841,723,000 JPY and operating cash flow of 1,292,903,000 JPY support its growth initiatives and financial flexibility. The company's risk assessment indicates a low probability of liquidity and dilution issues, with no immediate filing-based flags detected. The dilution potential is also low, with no significant dilution sources identified in recent filings. The company's conservative capital structure and strong cash reserves further mitigate financial risk. Recent events and filings show that Kanamic Network Co Ltd has maintained a stable financial position, with no major disruptions or strategic shifts reported. The company's earnings have been in line with analyst expectations, with the last actual EPS of 23.42 JPY compared to the mean estimate of 29.10 JPY. The company's performance suggests a consistent and reliable earnings profile.